Humacyte, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
HUMA, HUMAW on Nasdaq
Location
2525 East North Carolina Highway 54, Durham, NC

Insiders trading volume in the past year

Humacyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ayabudge LLC 10%+ Owner $9.75M Aug 17, 2023
Brady W. Dougan Director $8.38M -$27M -76.3% Jan 21, 2025
Laura E. Niklason President, CEO and Director, Director $8.38M -$27M -76.3% Jan 21, 2025
Gordon M. Binder Director $1.41M +$668K +89.5% May 15, 2024
Max N. Wallace Director $406K +$50K +14.1% Jun 13, 2024
Kathleen Sebelius Director $222K -$28K -11.2% Sep 10, 2024
Dale A. Sander CFO and Chief Corp. Deve. Off. $151K -$263K -63.5% Jan 21, 2025
Michael T. Constantino Director $74.4K +$39.7K +114% Dec 4, 2024
William Edward Tente Chief Regulatory Officer $62.5K Aug 26, 2021
Charles Bruce Green Director $9.82K Sep 13, 2024
Jeffrey Harold Lawson Chief Surgical Officer, Director $9.37K Aug 26, 2021
Heather Ledbetter Prichard Chief Operating Officer $0 -$1.56M -100% Jan 21, 2025
Yang Cao Chief Regulatory Officer Jan 21, 2025
Keith Anthony Jones Director Jun 13, 2024
Susan Windham-Bannister Director Jun 13, 2024
Todd Pope Director Jun 13, 2024
William John Scheessele Chief Commercial Officer Jan 21, 2025
Emery N. Brown Director Jun 13, 2024
Kiernan Thomas DeAngelis Chief Medical Officer Aug 26, 2021
Fresenius Medical Care Holdings Inc /Ny/ 10%+ Owner Aug 26, 2021
Rajiv Shukla Director Jun 15, 2023
Shamik J. Parikh Chief Medical Officer Jan 21, 2025
Diane Seimetz Director Jun 13, 2024
John Philip Bamforth Director Jun 13, 2024

Recent Insider Transactions by Companies or Individuals for Humacyte, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.